---
title: Scientific approaches to defining HPV vaccine-induced protective immunity
date: '2025-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39945620/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250213170915&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Seventeen years after the licensure of prophylactic human papillomavirus
  (HPV) L1 virus-like-particle vaccines, a defined antibody level that correlates
  with vaccine-induced protection against HPV infections and associated neoplasia
  is missing. In contrast, correlates of protection have been defined for many viral
  vaccines, including for the hepatitis B virus (HBV) vaccine. This review includes
  lessons learned from vaccination against HBV and the use of an established protective
  HBV ...
disable_comments: true
---
Seventeen years after the licensure of prophylactic human papillomavirus (HPV) L1 virus-like-particle vaccines, a defined antibody level that correlates with vaccine-induced protection against HPV infections and associated neoplasia is missing. In contrast, correlates of protection have been defined for many viral vaccines, including for the hepatitis B virus (HBV) vaccine. This review includes lessons learned from vaccination against HBV and the use of an established protective HBV ...